Stephen O'Connor
31Patents
8h-index
105Co-inventors
78Inventor score
Filing activity: Jan 24, 1995 → Apr 28, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6861502B1 | Polymers, their preparation and uses | Emerging Cross-Sectional Technologies | 21 | Expired |
| US6310095A | Inhibitors of protein isoprenyl transferases | Chemistry; Metallurgy | 17 | Expired |
| US5631401A | Inhibitors of protein farnesyltransferase and squalene synthase | Chemistry; Metallurgy | 16 | Expired |
| US6221865A | Inhibitors of protein isoprenyl transferases | Chemistry; Metallurgy | 14 | Expired |
| US6660752B2 | 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists | Chemistry; Metallurgy | 12 | Expired |
| US6204293A | Inhibitors of protein isoprenyl transferases | Chemistry; Metallurgy | 10 | Expired |
| US6960601B2 | Preparation and use of imidazole derivatives for treatment of obesity | Chemistry; Metallurgy | 10 | Expired |
| US5783593A | Inhibitors of squalene synthetase and protein farnesyltransferase | Chemistry; Metallurgy | 10 | Expired |
| US7091228B2 | Preparation and use of aryl alkyl acid derivatives for the treatment of obesity | Chemistry; Metallurgy | 8 | Expired |
| US5567783A | Polyphosphazenes bearing crown ether and related podand side groups as solid solvents for ionic conduction | Chemistry; Metallurgy | 7 | Expired |
| US8431695B2 | Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases | Human Necessities | 4 | Active |
| US6699860B2 | Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists | Chemistry; Metallurgy | 4 | Expired |
| US8143393B2 | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | Human Necessities | 3 | Active |
| US11033629B2 | Oral formulations of kappa opioid receptor agonists | Human Necessities | 2 | Active |
| US5831115A | Inhibitors of squalene synthase and protein farnesyltransferase | Chemistry; Metallurgy | 2 | Expired |
| US8129379B2 | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | Human Necessities | 2 | Active |
| US6919371B2 | 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists | Chemistry; Metallurgy | 1 | Expired |
| US8063554B2 | Phosphorescent OLED | Emerging Cross-Sectional Technologies | 1 | Active |
| US7968576B2 | Preparation and use of aryl alkyl acid derivatives for the treatment of obesity | Chemistry; Metallurgy | 1 | Active |
| US6693123B2 | Inhibitors of protein isoprenyl transferases | Chemistry; Metallurgy | 1 | Expired |
| US8835422B2 | Substituted imidazoheterocycle derivatives | Chemistry; Metallurgy | 1 | Active |
| US7960377B2 | Substituted pyridoxazines | Chemistry; Metallurgy | 0 | Active |
| US9172052B2 | Phosphorescent OLED | Emerging Cross-Sectional Technologies | 0 | Active |
| US11986509B2 | Oligosaccharide formulations of kappa opioid receptor agonists | Human Necessities | 0 | Active |
| US7071207B2 | Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.